Menu

Back to Medication Guide

Lurasidone

Generic Name: Lurasidone

Brand Names: Latuda

Lurasidone is an atypical antipsychotic used for schizophrenia and bipolar depression with a favorable metabolic profile.

PsychiatricAntipsychotic

Drug Class

Atypical Antipsychotic (Second-Generation Antipsychotic)

Pregnancy

Not recommended during pregnancy unless clearly necessary. Third trimester use may cause extrapyramidal symptoms and withdrawal symptoms in the newborn. Enroll exposed patients in the National Pregnancy Registry for Atypical Antipsychotics.

Available Forms

Tablet

Dosage Quick Reference

These are general dosage guidelines. Your doctor will determine the appropriate dose for your specific situation.

ConditionStarting DoseMaintenance Dose
Schizophrenia (Adults)40 mg once daily with food (≥350 calories)40–160 mg once daily
Schizophrenia (Adolescents 13–17)40 mg once daily with food40–80 mg once daily
Bipolar I Depression (Adults, Monotherapy)20 mg once daily with food20–120 mg once daily
Bipolar I Depression (Adults, Adjunct with lithium or valproate)20 mg once daily with food20–120 mg once daily

Side Effects

Common Side Effects:

  • Somnolence and sedation
  • Akathisia (restlessness)
  • Nausea
  • Parkinsonism (tremor, rigidity)
  • Agitation

Serious Side Effects:

  • Neuroleptic malignant syndrome
  • Tardive dyskinesia
  • Metabolic syndrome
  • Orthostatic hypotension
  • Agranulocytosis

Drug Interactions

Major Interactions:

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin, ritonavir, voriconazole) — Contraindicated; dramatically increase lurasidone levels, raising the risk of serious adverse effects
  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, St. John’s Wort) — Contraindicated; substantially reduce lurasidone levels, rendering it ineffective
  • Moderate CYP3A4 inhibitors (e.g., diltiazem, erythromycin, fluconazole, grapefruit juice) — Lurasidone dose should not exceed 80 mg/day; monitor for increased side effects
  • CNS depressants (e.g., alcohol, benzodiazepines, opioids) — Additive sedation and cognitive impairment; use caution
  • Antihypertensive medications — Lurasidone can cause orthostatic hypotension; enhanced hypotensive effect when combined with blood-pressure-lowering drugs

Additional Information

Lurasidone is an atypical antipsychotic medication approved for the treatment of schizophrenia and bipolar depression. It offers a favorable metabolic profile compared to many other second-generation antipsychotics, making it an attractive option for patients requiring long-term antipsychotic therapy.

Mechanism of Action

Lurasidone functions as an antagonist at multiple receptor types:

  • Dopamine D2 receptors: Primary mechanism for antipsychotic effects
  • Serotonin 5-HT2A receptors: Contributes to reduced extrapyramidal symptoms
  • Serotonin 5-HT7 receptors: May contribute to antidepressant and procognitive effects
  • Alpha-2C adrenergic receptors: May enhance cognitive function

The drug has minimal affinity for histamine H1 and muscarinic M1 receptors, which accounts for its favorable metabolic and anticholinergic profile.

Available Formulations

Lurasidone is available as oral tablets:

  • 20 mg tablets
  • 40 mg tablets
  • 60 mg tablets
  • 80 mg tablets
  • 120 mg tablets

All tablets should be taken with food (at least 350 calories) to ensure adequate absorption.

Medical Uses

FDA-Approved Indications:

  • Schizophrenia in adults and adolescents (13-17 years)
  • Bipolar depression (depressive episodes associated with bipolar I disorder) as monotherapy or adjunctive therapy with lithium or valproate in adults
  • Bipolar depression in children and adolescents (10-17 years)

Lurasidone is particularly valuable for bipolar depression given limited treatment options for this phase of the illness.

Dosing Guidelines

Schizophrenia (Adults):

  • Starting dose: 40 mg once daily
  • Recommended range: 40-160 mg once daily
  • Maximum: 160 mg/day

Schizophrenia (Adolescents 13-17 years):

  • Starting dose: 40 mg once daily
  • Recommended range: 40-80 mg once daily
  • Maximum: 80 mg/day

Bipolar Depression:

  • Starting dose: 20 mg once daily
  • Recommended range: 20-120 mg once daily (monotherapy) or 20-80 mg (adjunctive)

Important Safety Information

Black Box Warnings:

  • Increased risk of death in elderly patients with dementia-related psychosis
  • Increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults

Contraindications:

  • Known hypersensitivity to lurasidone
  • Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole) or inducers (e.g., rifampin)

Warnings and Precautions:

  • Neuroleptic malignant syndrome
  • Tardive dyskinesia
  • Metabolic changes (monitor weight, glucose, lipids)
  • Orthostatic hypotension
  • Leukopenia and neutropenia
  • Seizures

Drug Interactions

  • Strong CYP3A4 inhibitors (ketoconazole, clarithromycin): Contraindicated
  • Strong CYP3A4 inducers (rifampin, carbamazepine): Contraindicated
  • Moderate CYP3A4 inhibitors (diltiazem): Reduce lurasidone dose by half
  • Grapefruit and grapefruit juice: Avoid

Special Populations

  • Hepatic Impairment: Reduce dose; maximum 80 mg/day for moderate impairment, 40 mg/day for severe
  • Renal Impairment: Maximum 80 mg/day for moderate to severe impairment
  • Elderly: Use lower starting doses
  • Pregnancy: May cause extrapyramidal symptoms and withdrawal in neonates

Frequently Asked Questions

Lurasidone absorption is significantly increased when taken with food containing at least 350 calories. Without food, blood levels may be too low for the medication to work effectively.
Lurasidone has a relatively favorable metabolic profile compared to many other atypical antipsychotics. Weight gain tends to be modest, and it has less impact on cholesterol and blood sugar than some alternatives. However, regular metabolic monitoring is still recommended.
Some improvement in symptoms may be noticed within 1 to 2 weeks, but full therapeutic effects for schizophrenia or bipolar depression may take 4 to 6 weeks of consistent dosing.
Take it with food as soon as you remember. If it is close to the time of your next dose, skip the missed one and resume your normal schedule. Do not double the dose.
No. Grapefruit and grapefruit juice inhibit CYP3A4 and can increase lurasidone levels in the blood, raising the risk of side effects. Avoid grapefruit products during treatment.
Somnolence (drowsiness) is a common side effect, particularly when starting therapy or increasing the dose. Taking it in the evening with dinner may help manage this side effect. Avoid driving until you know how it affects you.

Questions to Ask Your Doctor

Consider discussing these topics at your next appointment:

  • Ask your doctor about regular blood tests to monitor fasting blood sugar, cholesterol, and triglycerides during treatment.
  • Discuss any medications you take that may be CYP3A4 inhibitors or inducers, as these are contraindicated with lurasidone.
  • Ask about signs of tardive dyskinesia (involuntary movements) and neuroleptic malignant syndrome, which are rare but serious side effects.
  • Discuss whether lurasidone is appropriate if you have a history of seizures, cardiovascular disease, or diabetes.
  • Ask how long you should remain on lurasidone and what the plan is for monitoring your response.

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.

Questions About This Medication?

Talk to your doctor or pharmacist about whether Lurasidone is right for you.

Contact Us

Call: (727) 820-7800